Christopher James Stevens

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Martin Wilson, as attorney-in-fact for Christopher James Stevens
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher James Stevens:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. Chief Operating Officer Common Stock 469,129 $1,782,690 $3.80 11 Feb 2026 Direct
ROCKET PHARMACEUTICALS, INC. Chief Operating Officer Stock Option (Right to Buy) 93,037 11 Feb 2026 Direct

Insider Reports Filed by Christopher James Stevens

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCKT ROCKET PHARMACEUTICALS, INC. 11 Feb 2026 2 $0 4 Chief Operating Officer 13 Feb 2026, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 04 Aug 2025 2 $0 4 Chief Operating Officer 06 Aug 2025, 16:11
RCKT ROCKET PHARMACEUTICALS, INC. 07 Jul 2025 0 $0 3 Chief Operating Officer No securities beneficially owned. Exhibit 24: Power of Attorney 04 Aug 2025, 16:16